The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Patients taking semaglutide, the active ingredient in Ozempic, were less likely to develop Alzheimer’s. Randomized clinical trials are needed to pin down the exact cause of this difference in risk.

Ozempic Users Are Seeing a Surprising Drop in Alcohol and Drug Cravings Diabetes drugs show surprising promise in reducing alcohol and opioid use ...

Weight loss drug Ozempic may also reduce the risk of dementia, suggests a new study. American researchers found that semaglutide - the active ingredient in Ozempic and another weight loss ...

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

More evidence suggests that medications such as Ozempic and Mounjaro, originally developed for diabetes and then approved for obesity, have benefits that go beyond these conditions.

A simple oversight could end up costing Danish pharma giant Novo Nordisk A/S (NYSE: NVO) billions in potential losses on its blockbuster weight-loss and diabetes drug, Ozempic.

Novo Nordisk (NYSE: NVO) has permanently forfeited Canadian patent protection for semaglutide—the blockbuster active ingredient in Ozempic and Wegovy—after failing to pay a routine $450 maintenance ...

What you really need to know about Ozempic – and how it impacts your relationship with food It's the revolutionary new pharmaceutical product that has taken the world by storm as the latest ...

New research suggests, Ozempic might now support heart health, decreasing the likelihood of cardiac events even without type-2 diabetes. Doctor shares insights on the topic.

Wondering about Ozempic? These questions reveal your deeper values and how to make decisions that follow your moral compass.